Our data highlighted that upon drug treatment pulmonary tumor growth is decreased, and a defined tumor-enriched epithelial subpopulation is affected by shutting down EGFR signaling and cell growth, while the normal epithelial components are virtually unaffected. Here, EGFR is linked to neoplasm.